Biodegradable nanoparticles for drug and gene delivery to cells and tissue

被引:1980
作者
Panyam, J
Labhasetwar, V
机构
[1] Univ Nebraska, Med Ctr, Dept Pharmaceut Sci, Nebraska Med Ctr 986025, Omaha, NE 68198 USA
[2] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA
关键词
nanotechnology; sustained release; biodegradable polymers; protein delivery; gene therapy;
D O I
10.1016/S0169-409X(02)00228-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Biodegradable nanoparticles formulated from poly (S,L-lactide-co-glycolide) (PLGA) have been extensively investigated for sustained and targeted/localized delivery of different agents including plasmid DNA, proteins and peptides and low molecular weight compounds. Research about the mechanism of intracellular uptake of nanoparticles, their trafficking and sorting into different intracellular compartments, and the mechanism of enhanced therapeutic efficacy of nanoparticleencapsulated agent at cellular level is more recent and is the primary focus of the review. Recent studies in our laboratory demonstrated rapid escape of PLGA nanoparticles from the endo-lysosomal compartment into cytosol following their uptake. Based on the above mechanism, various potential applications of nanoparticles for delivery of therapeutic agents to the cells and tissue are discussed. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:329 / 347
页数:19
相关论文
共 144 条
  • [1] Ahn YK, 1999, CATHETER CARDIO INTE, V48, P324, DOI 10.1002/(SICI)1522-726X(199911)48:3<324::AID-CCD20>3.0.CO
  • [2] 2-K
  • [3] Ajani A E, 2001, Cardiovasc Radiat Med, V2, P107, DOI 10.1016/S1522-1865(00)00081-0
  • [4] Inhibition of neointima formation after experimental coronary artery stenting -: A new biodegradable stent coating releasing hirudin and the prostacyclin analogue iloprost
    Alt, E
    Haehnel, I
    Beilharz, C
    Prietzel, K
    Preter, D
    Stemberger, A
    Fliedner, T
    Erhardt, W
    Schömig, A
    [J]. CIRCULATION, 2000, 101 (12) : 1453 - 1458
  • [5] Alt E, 1998, Semin Interv Cardiol, V3, P177
  • [6] Biodegradation and biocompatibility of PLA and PLGA microspheres
    Anderson, JM
    Shive, MS
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1997, 28 (01) : 5 - 24
  • [7] Axel DI, 1997, CIRCULATION, V96, P636
  • [8] Azrin MA, 1997, CATHETER CARDIO DIAG, V41, P232, DOI 10.1002/(SICI)1097-0304(199707)41:3<232::AID-CCD2>3.0.CO
  • [9] 2-7
  • [10] The blood-brain barrier and oncology: new insights into function and modulation
    Bart, J
    Groen, HJM
    Hendrikse, NH
    van der Graaf, WTA
    Vaalburg, W
    de Vries, EGE
    [J]. CANCER TREATMENT REVIEWS, 2000, 26 (06) : 449 - 462